Log in to save to my catalogue

Tumor-penetrating peptide fused to a pro-apoptotic peptide facilitates effective gastric cancer ther...

Tumor-penetrating peptide fused to a pro-apoptotic peptide facilitates effective gastric cancer ther...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1941291394

Tumor-penetrating peptide fused to a pro-apoptotic peptide facilitates effective gastric cancer therapy

About this item

Full title

Tumor-penetrating peptide fused to a pro-apoptotic peptide facilitates effective gastric cancer therapy

Publisher

Greece: D.A. Spandidos

Journal title

Oncology reports, 2017-04, Vol.37 (4), p.2063-2070

Language

English

Formats

Publication information

Publisher

Greece: D.A. Spandidos

More information

Scope and Contents

Contents

KLA (sequence, KLAKLAKKLAKLAK) is a peptide which leads to programmed cell death by disrupting the mitochondrial membrane. However, low penetration in tumors greatly limits its application and efficacy. To develop a KLA-based cancer therapy, KLA-iRGD, a recombinant protein was constructed. It consists of the KLA peptide and iRGD (CRGDKGPDC), a tumo...

Alternative Titles

Full title

Tumor-penetrating peptide fused to a pro-apoptotic peptide facilitates effective gastric cancer therapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_1941291394

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1941291394

Other Identifiers

ISSN

1021-335X

E-ISSN

1791-2431

DOI

10.3892/or.2017.5440

How to access this item